Up­dat­ed: Mer­ck buys Prometheus for $10.8B, bring­ing pre­ci­sion can­cer chops to a po­ten­tial IBD block­buster

Mer­ck will buy Prometheus Bio­sciences for $10.8 bil­lion, fu­el­ing a red-hot M&A mar­ket as the on­col­o­gy pow­er­house looks to bring its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.